The Licensing Company Company Profile

22:26 EDT 19th March 2018 | BioPortfolio

TLC is a new breed of licensing company, constantly evolving and nimble enough to provide an individualised service and personal relationships, but large enough to create and sustain global impact.

In the past 12 months we've generated in excess of £800 million of retail turnover for our client's brands.

With offices in four of the worlds top five consumer markets, we are at the heart of what's happening.

We are a talented group of people, with the spirit and experience to nurture and develop opportunities for brands worldwide.


Suite TwoCumberland House
Kensington Road
W8 5NX
United Kingdom


Phone: 44 (0)20 7368 0066
Fax: 44 (0)20 7368 0077

News Articles [175 Associated News Articles listed on BioPortfolio]

Compulsory Licensing And Compounded Orkambi: Solutions For Excessive Prices In The Netherlands?

Compulsory licensing, new R&D models, and pharmaceutical compounding are among measures that could help secure lower drugs prices, according to...   

Bayer inks another $1billion-plus in-licensing deal

Within a matter of a week, German pharma major Bayer has signed another more than $1 billion licensing…

vTv Therapeutics inks licensing deal for PPAR-delta program

Hot on the heels of an out-licensing deal for China, vTv Therapeutics has entered into a global agreement…

PhaseBio signs licensing deal to develop reversal agent for MedImmune's Brilinta

An exclusive global licensing agreement was signed by PhaseBio Pharmaceuticals and MedImmune for the development of MedImmune -More- 

Deal Making in 2012- What Next? Part 1- Licensing

Part 1:In this episode Helen Wright talks to Fintan Walton,CEO PharmaVentures, Shaun Grady, VP Strategic Partnering Business Development, AstraZeneca and Andy Richards, BioTech Entrepreneur about the ...

Valeant Announces Licensing Agreement With Kaken Pharmaceutical Co., Ltd. ...

Under the terms of the licensing agreement, Kaken has granted to Valeant an exclusive license to develop and commercialize topical products containing KP-470 to treat Read more...

Avacta signs licensing deal with Glythera after successful trial

Avacta Group has signed a licensing agreement with Glythera for its Affimer technology after a successful proof-of-concept study.

Novartis Reaches Licensing, Supply Agreement With Spark For LUXTURNA Outside US

BASEL (dpa-AFX) - Novartis (NVS) announced a licensing agreement with Spark Therapeutics covering development, registration and commercialization rights to voretigene neparvovec in markets outside...

PubMed Articles [67 Associated PubMed Articles listed on BioPortfolio]

Rapid DNA replication origin licensing protects stem cell pluripotency.

Complete and robust human genome duplication requires loading MCM helicase complexes at many DNA replication origins, an essential process termed origin licensing. Licensing is restricted to G1 phase ...

Scope and Nature of Pain- and Analgesia-Related Content of the United States Medical Licensing Examination (USMLE).

"The ongoing opioid crisis lies at the intersection of two substantial public health challenges-reducing the burden of suffering from pain and containing the rising toll of the harms that can result f...

Performance of candidates disclosing dyslexia with other candidates in a UK medical licensing examination: cross-sectional study.

The aim of this study was to compare performance of candidates who declared an expert-confirmed diagnosis of dyslexia with all other candidates in the Applied Knowledge Test (AKT) of the Membership of...

Editorial: In Good Company.

Bacteria and fungi in day-old turkeys vary among companies, collection periods, and breeder flocks.

Microbial colonization of the intestinal tract of commercial poultry is highly variable, likely due to the fact that poults and chicks are hatched and raised without exposure to adult birds and their ...

Clinical Trials [86 Associated Clinical Trials listed on BioPortfolio]

Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago

To continue the comprehensive research program on the epidemiology of cardiovascular and other major chronic diseases, including cancer and diabetes, in four Chicago population cohorts. T...

Immunogenicity and Safety of Kinrix + MMR With and Without Varicella Vaccine in Healthy Children 4-6 Years

The purpose of the study is to evaluate the immunogenicity and safety of Kinrix when co-administered with varicella (Varivax® [varicella virus vaccine live], Merck and Company) and MMR va...

Annual Study for Fluarix Registration

A pre-requisite to the yearly licensing process of the Influenza vaccine (FluarixTM/ Influsplit SSW®) is to demonstrate in clinical studies, the immunogenicity and reactogenicity of the v...

Yearly Strain Variation Study, 2010/2011

The purpose of the study is to verify the immunogenicity and tolerance of a trivalent seasonal influenza vaccine with strain composition according to WHO/EU recommendation for the 2010/201...

A Post-Marketing Safety Study of GSK Bio IPV Vaccine (PoliorixTM) in Korean Children

Following licensing of PoliorixTM in Korea, this study will collect safety data about the routine use of this vaccine in 600 children according to the regulations of Korean Food and Drugs ...

Companies [1839 Associated Companies listed on BioPortfolio]

The Licensing Company

TLC is a new breed of licensing company, constantly evolving and nimble enough to provide an individualised service and personal relationships, but large enough to create and sustain global impact.In ...

Pragma Pharmaceuticals

Fera Pharmaceuticals is a privately held company. The company goal is to realize opportunities via acquisitions, in-licensing, developing and marketing abbreviated new drug ...


Hemosol BioPharma Inc. is a privately held specialty biopharmaceutical company wholly owned by Catalyst Fund Limited Partnership II. The Company is focused primarily on the development and manufactur...

Ore Pharmaceutical Holdings Inc.

Ore Pharmaceutical Holdings Inc. (the “Company”) is a pharmaceutical asset management company. The Company acquires interests in pharmaceutical assets whose value, it be...

EOC Pharma Group

EOC is a fast-growing, Shanghai-based biopharmaceutical company that is focused on the in-licensing of innovative global oncology products, and developing, manufacturing and comme...

More Information about "The Licensing Company" on BioPortfolio

We have published hundreds of The Licensing Company news stories on BioPortfolio along with dozens of The Licensing Company Clinical Trials and PubMed Articles about The Licensing Company for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Licensing Company Companies in our database. You can also find out about relevant The Licensing Company Drugs and Medications on this site too.

Quick Search


Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Corporate Database Quicklinks

Searches Linking to this Company Record